CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

Medtronic Launches Efficio™ Software to facilitate Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II

admin - 1
Jan. 23, 2020: Medtronic announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug delivery system, that will allow...

FDA approves Tazverik (tazemetostat) for the treatment of adults and pediatric patients with metastatic or locally advanced epithelioid sarcoma

admin - 0
Jan 23, 2020: U.S. FDA granted accelerated approval to Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older...

Celularity Announces FDA Clearance of IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy for glioblastoma multiforme (GBM)

admin - 0
Jan 22, 2020: U.S. Food and Drug Administration (FDA) has cleared the Celularity’s Investigational New Drug (IND) Application for CYNK-001 in patients with glioblastoma...

FDA Approves Medtronic Micra™ AV, the World’s Smallest Pacemaker with atrioventricular (AV) synchrony for the treatment of patients with AV block

admin - 0
Jan. 22, 202: U.S. FDA grants approval for Medtronic’s Micra™ AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony for the treatment of patients...

Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx for the treatment of hypertriglyceridemia

admin - 0
Jan 22, 2020: Akcea Therapeutics and Ionis Pharmaceuticals announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of patients with hypertriglyceridemia,...

European Commission approves Darzalex® in combination with bortezomib, thalidomide and dexamethasone for multiple myeloma

admin - 0
Jan 22, 2020: The European Commission (EC) approved marketing authorisation for Janssen Pharmaceutical’s Darzalex (daratumumab) in combination with bortezomib, thalidomide and dexamethasone (VTd) for...

Jazz Pharmaceuticals reported that EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

admin - 0
Jan 22, 2020:Jazz Pharmaceuticals reported that the European Commission endorsed Sunosi® (solriamfetol) to improve alertness and lessen unnecessary daytime languor (EDS) in grown-ups with...

AstraZeneca’s ‘Desire Zero Carbon’ system to take out outflows by 2025 and be carbon negative over the whole worth chain by 2030

admin - 0
Jan 22, 2020: AstraZeneca revealed a goal-oriented program for zero carbon outflows from its worldwide activities by 2025 and to guarantee its whole worth...

Free “LabXchange” Science Education Accelerator Launched By the Amgen Foundation And Faculty of Arts and Sciences at Harvard

admin - 0
Jan 22, 2020: The Amgen Foundation alongside the Faculty of Arts and Sciences at Harvard University (Harvard FAS) declared the worldwide dispatch of LabXchange™,...

US FDA grants priority review of GlaxoSmithKline’s belantamab mafodotin for patients with relapsed or refractory multiple myeloma

admin - 0
Jan 21, 2020: GlaxoSmithKline declared that the US FDA allowed a need audit for the organization's Biologics License Application (BLA) looking for endorsement of...

The U.S.FDA approved Horizon Therapeutics Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease

admin - 0
Jan 21, 2020:  The U.S. FDA approved Horizon Therapeutics Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where...

Supernus Announces U.S. FDA Acceptance for Review of the New Drug Application for SPN-812 for the Treatment of ADHD

admin - 0
Jan. 21, 2020: Supernus Pharmaceuticals reported that the U.S. FDA has discovered the New Drug Application (NDA) for SPN-812(serotonin norepinephrine modulating agent) for the...
1...606162...65Page 61 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved